Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Hao, J. W.
  • Campagnolo, D.
  • Liu, R. L.
  • Piao, W. H.
  • Shi, S.
  • Hu, B. Y.
  • Xiang, Rong
  • Zhou, Q. H.
  • Vollmer, T.
  • Van Kaer, L.
  • La Cava, A.
  • Shi, F. D.

publication date

  • April 2011

journal

  • Annals of Neurology  Journal

subject areas

  • Adult
  • Animals
  • Antibodies, Monoclonal
  • Autoimmunity
  • CD8-Positive T-Lymphocytes
  • Cell Proliferation
  • Central Nervous System
  • Cytokines
  • Encephalomyelitis, Autoimmune, Experimental
  • Female
  • Flow Cytometry
  • Granzymes
  • Humans
  • Immunotherapy
  • Inflammation
  • Interleukin-2
  • Killer Cells, Natural
  • Leukocytes, Mononuclear
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred Strains
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting
  • Perforin
  • Reverse Transcriptase Polymerase Chain Reaction
  • Severity of Illness Index
  • T-Lymphocytes, Regulatory
scroll to property group menus

Identity

PubMed Central ID

  • PMC3082615

International Standard Serial Number (ISSN)

  • 0364-5134

Digital Object Identifier (DOI)

  • 10.1002/ana.22339

PubMed ID

  • 21425186
scroll to property group menus

Additional Document Info

start page

  • 721

end page

  • 734

volume

  • 69

issue

  • 4

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support